Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02981888 · ClinicalTrials.gov registry record
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 100
- Enrollment target
NCT02981888: Completed study, sponsored by Indiana University.
NCT02981888 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02981888 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the relationship between the bile acids, fatty acids (fatty acids are part of the diet) and bacteria that are present in the intestines.
Primary Outcome
Stool samples will be collected over 2 days for measurement of fecal bile acids (µmol/48h) by high performance liquid chromatography-mass spectometry
Interventions
- RADIATION X-Ray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2023-04-27 |
What the finished NCT02981888 record still lists
NCT02981888 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which X-Ray is the first listed.
NCT02981888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02981888 about?
NCT02981888 is a clinical study titled "Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome". The purpose of this study is to find out the relationship between the bile acids, fatty acids (fatty acids are part of the diet) and bacteria that are present in the intestines.
What is the current status of trial NCT02981888?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-07-01. Estimated completion is 2023-04-27.
What interventions are being tested in trial NCT02981888?
The interventions under investigation include: X-Ray (RADIATION).
Who is sponsoring clinical trial NCT02981888?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI